Research
ILEOSTIM trial: efferent loop stimulation before ileostomy reversal
Dr. Patricia Tejedor contributes to this multicentre trial published in Colorectal Disease (2026), assessing whether preoperative efferent loop stimulation reduces postoperative ileus following ileostomy reversal. Although the primary endpoint did not reach statistical significance, the intervention group showed a clinically relevant reduction (7.6% vs 16.4%), supporting further research in perioperative optimisation.
Read full analysis
Research
Cytoreductive surgery for peritoneal metastases in GIST
Review published in Clinical and Translational Oncology featuring the contribution of Prof. Luis González Bayón. Cytoreductive surgery in GIST with peritoneal metastases — performed after 6-12 months of TKI therapy and decided in multidisciplinary teams — yields 5-year overall survival rates of up to 80% in carefully selected cases.
Read full analysis
Research
ERAS consensus in primary retroperitoneal sarcoma surgery
Dr. Pablo Lozano Lominchar, member of the Quenet Torrent team, is the first author of this international consensus with 42 ERAS recommendations graded using GRADE and validated by Delphi between the Spanish Society of Surgeons and the Portuguese Sarcoma Group.
Read full analysis
Research
Two-stage surgery with HIPEC in pseudomyxoma peritonei
Pioneering study demonstrating the feasibility and efficacy of a two-stage surgical strategy with HIPEC for voluminous pseudomyxoma peritonei, achieving complete pathological response in all patients with no mortality.
Read full analysis
Research
What does the PRODIGE 7 study teach us?
The PRODIGE 7 study, led by Prof. Dr. François Quenet, provides fundamental data on the role of HIPEC with oxaliplatin in peritoneal carcinomatosis of colorectal origin.
Read full analysis
